VIVOPHARM Trademark

Trademark Overview


On Wednesday, November 8, 2023, a trademark application was filed for VIVOPHARM with the United States Patent and Trademark Office. The USPTO has given the VIVOPHARM trademark a serial number of 79385184. The federal status of this trademark filing is REGISTERED as of Tuesday, March 18, 2025. This trademark is owned by VivoPharm Pty Ltd. The VIVOPHARM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in relation to pharmaceuticals; pre-clinical studies, testing and evaluation relating to the efficacy, toxicology and safety of pharmaceutical treatments, in particular bioanalytical studies of pharmaceutical treatments; design of tests, evaluations and studies in relation to the efficacy, toxicology and safety, in particular bioanalytic studies of pharmaceuticals being pharmaceutical product evaluation; scientific and technological services, namely, analysis of statistical data and preparation of reports in the fields of medical and scientific research; provision of consultancy, information and advisory services in relation to the foregoing
vivopharm

General Information


Serial Number79385184
Word MarkVIVOPHARM
Filing DateWednesday, November 8, 2023
Status700 - REGISTERED
Status DateTuesday, March 18, 2025
Registration Number7726145
Registration DateTuesday, March 18, 2025
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements


Goods and ServicesResearch and development in relation to pharmaceuticals; pre-clinical studies, testing and evaluation relating to the efficacy, toxicology and safety of pharmaceutical treatments, in particular bioanalytical studies of pharmaceutical treatments; design of tests, evaluations and studies in relation to the efficacy, toxicology and safety, in particular bioanalytic studies of pharmaceuticals being pharmaceutical product evaluation; scientific and technological services, namely, analysis of statistical data and preparation of reports in the fields of medical and scientific research; provision of consultancy, information and advisory services in relation to the foregoing
Description of MarkThe mark consists of the stylized wording "VIVOPHARM" with "VIVO" appearing in red and "PHARM" appearing in blue, to the right of which is the design of an incomplete angled circle made of two curved lines, with the left curve being gray and the right being blue. The letters "RM" intersect with the circle.
Indication of Colors claimedThe color(s) red, blue, and gray is/are claimed as a feature of the mark.
Pseudo MarkVIVO PHARM

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVivoPharm Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameVivoPharm Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameVivoPharm Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Thursday, December 14, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 19, 2023APPLICATION FILING RECEIPT MAILED
Sunday, May 12, 2024LIMITATION OF GOODS RECEIVED FROM IB
Monday, June 17, 2024ASSIGNED TO EXAMINER
Tuesday, June 18, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 19, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, July 7, 2024LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Monday, July 8, 2024REFUSAL PROCESSED BY MPU
Monday, July 8, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, July 28, 2024REFUSAL PROCESSED BY IB
Tuesday, July 30, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 30, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 30, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 30, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 30, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 30, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 18, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, March 18, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 13, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, May 13, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, May 31, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 18, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 25, 2025FINAL DISPOSITION PROCESSED
Thursday, September 25, 2025FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 18, 2025FINAL DECISION TRANSACTION PROCESSED BY IB